Abstract
Chronic treatment (2 weeks) with piracetam (500 mg/kg, once daily PO) elevatedm-cholinoceptor density in the frontal cortex of aged (18 months) female mice by about 30–40%, but had no effect onm-cholinoceptor density in the frontal cortex of young (4 weeks) mice. The effect of piracetam onm-cholinoceptor density as determined by the specific binding of tritiated QNB was not affected by concomitant daily treatment with either choline (200 mg/kg) or scopolamine (4 mg/kg). It is concluded that the effect of piracetam onm-cholinoceptor density could explain the positive effects which have been reported for combinations of cholinergic precursor treatment with piracetam on memory and other cognitive functions in aged experimental animals and patients and could also represent part of the possible mechanism of action of piracetam alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartus RT, Dean RL, Sherman KA, Friedman E, Beer B (1981) Profound effect of combining choline and piracetam on memory enhancement and cholinergic functions in aged rats. Neurobiol Aging 2:3–8
Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417
Bering B, Müller WE (1985) Interaction of piracetam with several neurotransmitter receptors in the central nervous system. Arzneimittelforschung 35:1350–1352
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19:1–28
Davidson M, Mohs RC, Hollander E, Zemishlany Z, Powchik P, Ryan T, Davis KL (1987) Lecithin and piracetam in Alzheimer's disease. Biol Psychiatry 22:112–114
Fontani G, Grazzi F, Meucci M (1984) Effect of piracetam plus choline treatment on hipppocampal rhythmic slow activity (RSA) and behavior in rabbits. Life Sci 35:1183–1189
Franklin SR, Sethy VH, Tang AH (1986) Amnesia produced by intracerebroventricular injections of hemicholinium-3 in mice was prevented by pretreatment with piracetam-like compounds. Pharmacol Biochem Behav 25:925–927
Freund G (1980) Cholinergic receptor loss in brains of aging mice. Life Sci 26:371–375
Freund G, Brophy TR, Scott JD (1986) Membrane fluidization increases low-affinity muscarinic receptor binding in brain; changes with aging. Exp Gerontol 21:37–44
Freund G (1984) Neurotransmitter function in relation to aging and alcoholism. In: Hartford JT, Samorajski T (eds) Alcoholism in the Elderly. Raven Press, New York, pp 65–83
Friedman E, Sherman KA, Ferris SH, Reisberg B, Bartus RT, Schneck MK (1981) Clinical response to choline plus piracetam in senile dementia: relation to red-cell choline levels. N Engl J Med 304:1490–1491
Giurgea CE, Greindl M-G, Preat S (1983) Nootropic drugs and aging. Acta Psychiatr Belg 83:349–358
Growdon JH, Corkin S, Huff FJ, Rosen TJ (1986) Piracetam combined with lecithin in the treatment of Alzheimer's disease. Neurobiol Aging 7:269–276
Iversen LL (1986) The cholinergic hypothesis of dementia TIPS suppl. (Subtypes of muscarinic receptors II)
Johns CA, Haroutunian V, Greenwald BS, Mohs RC, Davis BM, Kanof P, Horvath TB, Davis KL (1985) Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug Dev Res 5:77–96
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Pedata F, Moroni F, Pepeu GC (1984) Effect of nootropic agents on brain cholinergic mechanism. Clin Neuropharmacol [Suppl 1] 7:S 416
Pedigo NW, Polk DM (1985) Reduced muscarinic receptor plasticity in frontal cortex of aged rats after chronic administration of cholinergic drugs. Life Sci 37:1443–1449
Pedigo NW, Minor LD, Krumrei TN (1984) Cholinergic drug effects and brain muscarinic receptor binding in aged rats. Neurobiol Aging 5:227–233
Pilch H, Müller WE (1987) Chronic treatment with choline or scopolamine indicates the presence of muscarinic cholinergic receptor plasticity in the frontal cortex of young but not of aged mice. J Neural Transm (in press)
Platel A, Jalfre M, Pawelec C, Roux S, Porsolt RD (1984) Habituation of exploratory activity in mice: effects of combinations of piracetam and choline on memory processes. Pharmacol Biochem Behav 21:209–212
Pomara N, Block R, Moore N, Rhiew HB, Berchou R, Stanley N, Gershon S (1984) Combined piracetam and cholinergic precursor treatment for primary degenerative dementia. IRCS Med Sci 12:388–389
Pugsley TA, Shih YH, Coughenour L, Stewart SF (1983) Some neurochemical properties of pramiracetam (Cl-879), a new cognition-enhancing agent. Drug Dev Res 3:407–420
Quirion R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NPV, Gauthier S (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer type. Can J Neurol Sci 13:503–510
Shih YH, Pugsley TA (1985) The effects of various cognition-enhancing drugs on in vitro rat hippocampal synaptosomal sodium dependent high affinity choline uptake. Life Sci 36:2145–2152
Smith RC, Vroulis G, Johnson R, Morgan R (1984) Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease. Psychopharmacol Bull 20:542–545
Terry RD, Katzman R (1983) Senile dementia of the Alzheimer type. Ann Neurol 14:497–506
Trovarelli G, Gaiti A, De Medio G, Brunetti M, Porcellati G (1984) Biochemical studies on the nootropic drug oxiracetam in brain. Clin Neuropharmacol [Suppl 1] 7:S 418
Valzelli L, Bernasconi S, Sala A (1980) Piracetam activity might differ according to the age of the recipient mouse. Int Pharmacopsychiatry 15:150–156
Viticchi C, Gentile S, Piantanelli L (1984) Centrophenoxine-induced increase of beta-adrenoceptor density in brain cortex of old mice. Arch Gerontol Geriatr 3:77–82
Waller SB, London ED (1983) Age-differences in choline acetyl-transferase activities and muscarinic receptor binding in brain regions of C 57 BL/6J mice. Exp Gerontol 18:419–425
Woelk H (1979) Effects of piracetam on the incorporation of32P into the phospholipids of neurons and glial cells isolated from rabbit cerebral cortex. Pharmacopsychiatry 12:251–256
Wood WG, Gorka C, Armbrecht HJ, Williamson LS, Strong R (1986) Fluidizing effects of centrophenoxine in vitro on brain and liver membranes from different age groups of mice. Life Sci 39:2089–2095
Wurtman RJ, Fernstrom JD (1976) Control of brain neurotransmitter synthesis by precursor availability and nutritional state. Biochem Pharmacol 25:1691–1696
Wurtman RJ, Magill SG, Reinstein DK (1981) Piracetam diminishes hippocampal ACh levels in rats. Life Sci 28:1091–1093
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pilch, H., Müller, W.E. Piracetam elevates muscarinic cholinergic receptor density in the frontal cortex of aged but not of young mice. Psychopharmacology 94, 74–78 (1988). https://doi.org/10.1007/BF00735884
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00735884